Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Teratoma 1Intracranial Germ Cell CNS Tumor, Childhood 1Choriocarcinoma 1Carcinoma, Embryonal 1

Interventions

Ifosfamide 7Etoposide 7Cisplatin 6Filgrastim 5Carboplatin 5Thiotepa 4Paclitaxel 4pegfilgrastim 3Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Bleomycin 3etoposide phosphate 2Neoadjuvant Therapy 2Mesna 2Granulocyte Colony-Stimulating Factor 2sargramostim 1ribociclib 1pegylated granulocyte colony-stimulating factor 1palifosfamide lysine 1palbociclib 1ixabepilone 1isophosphamide mustard 1aldesleukin 1Vincristine 1Therapeutics 1Sunitinib 1Specimen Handling 1Second-Look Surgery 1Reoperation 1Radiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Teratoma × Second-Look Surgery × Clear all
NCT04684368 2026-05-05

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

Children's Oncology Group

Phase 2 Recruiting
160 enrolled

Choriocarcinoma, Teratoma, Carcinoma, Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡